相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs
R. E. Boyd et al.
GENE THERAPY (2016)
AAV-mediated and pharmacological induction of Hsp70 expression stimulates survival of retinal ganglion cells following axonal injury
J. M. K. Kwong et al.
GENE THERAPY (2015)
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
F. M. Mowat et al.
GENE THERAPY (2014)
Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials
A. L. Minella et al.
GENE THERAPY (2014)
RPE65 gene therapy slows cone loss in Rpe65-deficient dogs
F. M. Mowat et al.
GENE THERAPY (2013)
Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
George V. Aslanidi et al.
PLOS ONE (2013)
Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
Christine N. Kay et al.
PLOS ONE (2013)
In Vivo-Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
Deniz Dalkara et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Bioengineering of AAV2 Capsid at Specific Serine, Threonine, or Lysine Residues Improves Its Transduction Efficiency in Vitro and in Vivo
Nishanth Gabriel et al.
HUMAN GENE THERAPY METHODS (2013)
Immunology of AAV-mediated gene transfer in the eye
Keiman Willett et al.
FRONTIERS IN IMMUNOLOGY (2013)
Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa
Thomas J. Conlon et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Samuel G. Jacobson et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Gene therapy for retinal ganglion cell neuroprotection in glaucoma
A. M. Wilson et al.
GENE THERAPY (2012)
The Human Rhodopsin Kinase Promoter in an AAV5 Vector Confers Rod- and Cone-Specific Expression in the Primate Retina
Shannon E. Boye et al.
HUMAN GENE THERAPY (2012)
Changes in glucose transporter expression in monocytes of periparturient dairy cows
N. J. O'Boyle et al.
JOURNAL OF DAIRY SCIENCE (2012)
Advances in Glaucoma Treatment and Management: Neurotrophic Agents
Gerald J. Chader
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Retinal Ganglion Cell Gene Therapy and Visual System Repair
Mats Hellstroem et al.
CURRENT GENE THERAPY (2011)
Evaluation of Adeno-Associated Viral Vectors for Liver-Directed Gene Transfer in Dogs
Peter Bell et al.
HUMAN GENE THERAPY (2011)
Post-Injury Delivery of rAAV2-CNTF Combined with Short-Term Pharmacotherapy Is Neuroprotective and Promotes Extensive Axonal Regeneration after Optic Nerve Trauma
Mats Hellstroem et al.
JOURNAL OF NEUROTRAUMA (2011)
Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2011)
The Complex and Evolving Story of T cell Activation to AAV Vector-encoded Transgene Products
Lauren E. Mays et al.
MOLECULAR THERAPY (2011)
Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey
Luk H. Vandenberghe et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Intravitreal Injection of AAV2 Transduces Macaque Inner Retina
Lu Yin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Improvement of Visual Performance With Intravitreal Administration of 9-cis-Retinal in Rpe65-Mutant Dogs
Patricia M. Gearhart et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Biodegradable Intraocular Therapies for Retinal Disorders Progress to Date
Noriyuki Kuno et al.
DRUGS & AGING (2010)
rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters
W. A. Beltran et al.
GENE THERAPY (2010)
Autoimmunity, Recessive Diseases, and Gene Replacement Therapy
James M. Wilson
MOLECULAR THERAPY (2010)
Adeno-Associated Virus-Mediated Gene Transfer to Nonhuman Primate Liver Can Elicit Destructive Transgene-Specific T Cell Responses
Guangping Gao et al.
HUMAN GENE THERAPY (2009)
Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression
Li Zhong et al.
VIROLOGY (2008)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 α1-antitrypsin (AAT) vector in AAT-deficient adults
Mark L. Brantly et al.
HUMAN GENE THERAPY (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging
H Kim et al.
ANNALS OF BIOMEDICAL ENGINEERING (2005)
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
JW Streilein
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Ocular immune privilege: Therapeutic opportunities from an experiment of nature
JW Streilein
NATURE REVIEWS IMMUNOLOGY (2003)
Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time
BA Van Adel et al.
HUMAN GENE THERAPY (2003)
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
S Zolotukhin et al.
METHODS (2002)
分享论文
